Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-9-3
pubmed:abstractText
Type 2 diabetes develops due to a combination of insulin resistance and beta-cell failure and current therapeutics aim at both of these underlying causes. Several negative regulators of insulin signaling are known and are the subject of drug discovery efforts. We sought to identify novel contributors to insulin resistance and hence potentially novel targets for therapeutic intervention.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-10066179, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-10574462, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-10960473, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-11171109, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-11463863, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-11684658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-11752399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12493740, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12556524, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12730241, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12771949, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12777378, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-12791994, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-14657487, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-14769918, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15143191, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15186772, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15685170, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15713620, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15743841, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-15860415, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-17113751, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-17116687, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-18669619, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-7479768, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-8262969, http://linkedlifedata.com/resource/pubmed/commentcorrection/19727444-9670003
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e6871
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Negative regulators of insulin signaling revealed in a genome-wide functional screen.
pubmed:affiliation
Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't